Capital Analysts LLC Portfolio holdings
Capital Analysts is a Lincoln Investment company that provides a ready-made wealth management platform to independent financial professionals who serve affluent clients. Capital Analysts dates from 2012 and belongs to Lincoln Investment Capital Holdings; Lincoln Investment Planning, a brokerage and advisory firm under the same ownership, handles brokerage services for it and its advisors. Those advisors work across the United States as independent contractors, not employees. Their clients include individuals, high net worth individuals, trusts, foundations, businesses and charities, and Capital Analysts also offers its institutional advisory services to other advisers and trust companies. The portfolios it builds aim to be diversified and rest on asset allocation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$24.6M |
| 2 |
Goldman Sachs ETF Trust Goldman Sachs S&P 500 Premium Income ETF
GPIX
|
+$16.4M |
| 3 |
Fidelity Total Bond ETF
FBND
|
+$16.1M |
| 4 |
iShares Systematic Alternatives Active ETF
IALT
|
+$16M |
| 5 |
iShares Core Universal USD Bond ETF
IUSB
|
+$11.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$7.72M |
| 2 |
Citigroup
C
|
+$7.28M |
| 3 |
iShares Gold Trust
IAU
|
+$6.25M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.23M |
| 5 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$6.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 76.75% |
| 2 | Technology | 5.6% |
| 3 | Financials | 4.52% |
| 4 | Industrials | 2.67% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1101
National Grid
NGG
$84.7B
| $27K | ﹤0.01% |
319
-40
| -11% | -$3.4K |
2024 Q3
7 quarters
|
|
1102
Innovator Equity Defined Protection ETF - 1 Yr September
ZSEP
$262M
| $27K | ﹤0.01% |
996
| – | – |
2025 Q1
5 quarters
|
|
1103
Innovator Equity Defined Protection ETF - 1 Yr October
ZOCT
$223M
| $27K | ﹤0.01% |
992
| – | – |
2024 Q4
6 quarters
|
|
1104
Innovator Growth-100 Power Buffer ETF - November
NNOV
$73.2M
| $27K | ﹤0.01% |
859
| – | – |
2026 Q1
1 quarter
|
|
1105
BioMarin Pharmaceuticals
BMRN
$11.1B
| $26K | ﹤0.01% |
446
| – | – |
2021 Q4
18 quarters
|
|
1106
Dimensional International Small Cap Value ETF
DISV
$5.13B
| $26K | ﹤0.01% |
+657
| New | +$27.2K |
2026 Q2
0 quarters
|
|
1107
FT Vest US Equity Buffer ETF February
FFEB
$1.38B
| $26K | ﹤0.01% |
421
| – | – |
2024 Q1
9 quarters
|
|
1108
State Street SPDR S&P Global Infrastructure ETF
GII
$977M
| $26K | ﹤0.01% |
350
| – | – |
2019 Q1
29 quarters
|
|
1109
BNY Mellon Strategic Municipals
LEO
$379M
| $26K | ﹤0.01% |
4,091
-61
| -1% | -$389 |
2025 Q4
2 quarters
|
|
1110
Cloudflare
NET
$105B
| $26K | ﹤0.01% |
107
+5
| +5% | +$1.09K |
2025 Q3
3 quarters
|
|
1111
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.62B
| $26K | ﹤0.01% |
402
+1
| +0.2% | +$57 |
2018 Q4
30 quarters
|
|
1112
Cardinal Health
CAH
$63.4B
| $25K | ﹤0.01% |
106
-2
| -2% | -$416 |
2023 Q4
10 quarters
|
|
1113
Fidelity National Financial
FNF
$12.1B
| $25K | ﹤0.01% |
529
| – | – |
2024 Q4
6 quarters
|
|
1114
Fidelity MSCI Consumer Staples Index ETF
FSTA
$1.57B
| $25K | ﹤0.01% |
479
+2
| +0.4% | +$106 |
2021 Q1
21 quarters
|
|
1115
Interactive Brokers
IBKR
$35.1B
| $25K | ﹤0.01% |
292
-43
| -13% | -$3.58K |
2024 Q3
7 quarters
|
|
1116
Nuveen Quality Municipal Income Fund
NAD
$2.57B
| $25K | ﹤0.01% |
2,063
-1,432
| -41% | -$16.9K |
2025 Q4
2 quarters
|
|
1117
PPG Industries
PPG
$27.7B
| $25K | ﹤0.01% |
203
| – | – |
2015 Q3
43 quarters
|
|
1118
VanEck Pharmaceutical ETF
PPH
$1.11B
| $25K | ﹤0.01% |
232
| – | – |
2024 Q3
7 quarters
|
|
1119
DELISTED
Webster Financial
WBS
| $25K | ﹤0.01% |
329
| – | – |
2019 Q1
29 quarters
|
|
1120
Western Midstream Partners
WES
$16.9B
| $25K | ﹤0.01% |
578
+12
| +2% | +$517 |
2025 Q1
5 quarters
|
|
1121
iShares iBonds Dec 2034 Term Corporate ETF
IBDZ
$914M
| $25K | ﹤0.01% |
+960
| New | +$25K |
2026 Q2
0 quarters
|
|
1122
FT Vest Nasdaq-100 Moderate Buffer ETF - November
QMNV
$44.8M
| $25K | ﹤0.01% |
1,000
| – | – |
2024 Q4
6 quarters
|
|
1123
iShares iBonds Dec 2035 Term Corporate ETF
IBCA
$410M
| $25K | ﹤0.01% |
+980
| New | +$25.1K |
2026 Q2
0 quarters
|
|
1124
iShares iBonds Dec 2036 Term Corporate ETF
IBCB
$95.4M
| $25K | ﹤0.01% |
+1,000
| New | +$25.1K |
2026 Q2
0 quarters
|
|
1125
AerCap
AER
$26.6B
| $24K | ﹤0.01% |
161
-13
| -7% | -$1.85K |
2024 Q3
7 quarters
|
|
Similar funds
Capital Analysts LLC's Q2 2026 Portfolio in Review
As of Q2 2026, Capital Analysts LLC held 1,612 positions worth $4.34B, up 14% from $3.81B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital Analysts LLC deployed $223M of net new capital in Q2 2026, opening 75 new positions and adding to 544 existing holdings. Its largest new stake was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, up from 75% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Zoetis, an estimated $7.72M trimmed.
- Capital Analysts LLC's largest Q2 2026 buy was iShares Systematic Alternatives Active ETF: 571,327 shares worth $16M.
- Capital Analysts LLC added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $24.6M increase.
- Capital Analysts LLC's biggest Q2 2026 reduction was Zoetis, cutting an estimated $7.72M.
- Capital Analysts LLC fully exited Hershey in Q2 2026, selling an estimated $113K.
- Capital Analysts LLC's ten largest holdings make up 30% of its $4.34B portfolio in Q2 2026.
- Capital Analysts LLC opened 75 new positions and closed 76 in Q2 2026.
- Capital Analysts LLC's portfolio value rose 14% quarter-over-quarter to $4.34B.
Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.